226 related articles for article (PubMed ID: 17224907)
1. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo.
Schwartz B; Melnikova VO; Tellez C; Mourad-Zeidan A; Blehm K; Zhao YJ; McCarty M; Adam L; Bar-Eli M
Oncogene; 2007 Jun; 26(28):4049-58. PubMed ID: 17224907
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor AP-2alpha represses both the mucin MUC4 expression and pancreatic cancer cell proliferation.
Fauquette V; Aubert S; Groux-Degroote S; Hemon B; Porchet N; Van Seuningen I; Pigny P
Carcinogenesis; 2007 Nov; 28(11):2305-12. PubMed ID: 17621592
[TBL] [Abstract][Full Text] [Related]
4. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
5. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
Wang J; Yang Y; Xia HH; Gu Q; Lin MC; Jiang B; Peng Y; Li G; An X; Zhang Y; Zhuang Z; Zhang Z; Kung HF; Wong BC
Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
[TBL] [Abstract][Full Text] [Related]
6. Activator protein 2alpha transcription factor expression is associated with luminal differentiation and is lost in prostate cancer.
Ruiz M; Troncoso P; Bruns C; Bar-Eli M
Clin Cancer Res; 2001 Dec; 7(12):4086-95. PubMed ID: 11751506
[TBL] [Abstract][Full Text] [Related]
7. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9).
Troussard AA; Costello P; Yoganathan TN; Kumagai S; Roskelley CD; Dedhar S
Oncogene; 2000 Nov; 19(48):5444-52. PubMed ID: 11114721
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
9. The cartilage-specific transcription factor Sox9 regulates AP-2epsilon expression in chondrocytes.
Wenke AK; Grässel S; Moser M; Bosserhoff AK
FEBS J; 2009 May; 276(9):2494-504. PubMed ID: 19476490
[TBL] [Abstract][Full Text] [Related]
10. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
12. AP-2 regulates the transcription of estrogen receptor (ER)-beta by acting through a methylation hotspot of the 0N promoter in prostate cancer cells.
Zhang X; Leung YK; Ho SM
Oncogene; 2007 Nov; 26(52):7346-54. PubMed ID: 17525739
[TBL] [Abstract][Full Text] [Related]
13. Modulation of IFN-γ receptor 1 expression by AP-2α influences IFN-γ sensitivity of cancer cells.
Chen C; Guo L; Shi M; Hu M; Hu M; Yu M; Wang T; Song L; Shen B; Qian L; Guo N
Am J Pathol; 2012 Feb; 180(2):661-71. PubMed ID: 22182699
[TBL] [Abstract][Full Text] [Related]
14. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
[TBL] [Abstract][Full Text] [Related]
15. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
Zins K; Abraham D; Sioud M; Aharinejad S
Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
[TBL] [Abstract][Full Text] [Related]
16. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells.
Miyaki M; Tanaka K; Kikuchi-Yanoshita R; Muraoka M; Konishi M; Takeichi M
Oncogene; 1995 Dec; 11(12):2547-52. PubMed ID: 8545111
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells.
Wang Q; Sun Z; Yang HS
Oncogene; 2008 Mar; 27(11):1527-35. PubMed ID: 17828298
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MT1-MMP is insufficient to increase experimental liver metastasis of human colon cancer cells.
Yamamoto H; Noura S; Okami J; Uemura M; Takemasa I; Ikeda M; Ishii H; Sekimoto M; Matsuura N; Monden M; Mori M
Int J Mol Med; 2008 Dec; 22(6):757-61. PubMed ID: 19020773
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.
Llorens A; Rodrigo I; López-Barcons L; Gonzalez-Garrigues M; Lozano E; Vinyals A; Quintanilla M; Cano A; Fabra A
Lab Invest; 1998 Sep; 78(9):1131-42. PubMed ID: 9759657
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.
Chang TP; Yu SL; Lin SY; Hsiao YJ; Chang GC; Yang PC; Chen JJ
Cancer Res; 2010 Feb; 70(4):1656-67. PubMed ID: 20145123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
